Outstanding Contribution to Health Award
George Nakayama has been Senior Advisor since June 2020. From June 2019 to June 2020, he served as Chairman. Prior to that, he was Chairman and CEO since April 2017, and President and CEO from June 2010 to April 2017. Mr. Nakayama joined former Daiichi Group as President of Daiichi Suntory Pharma Co., Ltd. upon the spin-off of the Pharmaceutical Div. of Suntory Co., Ltd. in 2002. In 2006, he was appointed as Daiichi's General Manager, Business Planning Department and from April 2007, when Daiichi and Sankyo were fully integrated into Daiichi Sankyo Co., Ltd., he took responsibility for its overseas businesses as General Manager, EU US Business Management Department followed by General Manager, International Business Management Department.